Navigation Links
Follicle Count Test as Good as Hormone Tests in Predicting Ovarian Response

Researchers find that Follicle count test done using Transvaginal sonography is as good at predicting ovarian response as other// expensive and time consuming hormone tests.

As these tests are less costly and invasive than the current ovarian reserve tests, clinicians may in future consider using ultrasound scans of a woman's ovaries to predict her ovaries' response to IVF.

Research published today in Reproductive Biology and Endocrinology details how Janet Kwee et. al. from Vrije Universiteit Medical Centre in Amsterdam, The Netherlands studied 110 women aged 18-39 who had difficulty conceiving. She counted the number of antral follicles, small egg-bearing ovarian follicles about 2-10 mm in diameter, with transvaginal sonography (ultrasound).

Kwee compared the follicle count with ovarian volume with the results from ovarian reserve endocrine tests. The antral follicle count was an effective predictor of the number of eggs the patient would ultimately produce when her ovaries had been stimulated during IVF treatment.

A test that can be administered before IVF that indicates ovarian response might be used to counsel patients as to their chances of success, and help clinicians decide the starting dose of hormones used to stimulate the patient's ovaries for the best results. After around age 40, the ovaries' size decreases - an early sign that the number of follicles, and potential eggs, is depleted. Women with few eggs in their ovarian reserve are less likely to have an adequate ovarian response for successful IVF.

"The follicle count is just as good a test for ovarian response as expensive and time consuming endocrine tests," says Kwee, who adds that the count appears to be "the only test able to reliably predict low and high responders."

Source-Eurekalert
PRI
'"/>




Page: 1

Related medicine news :

1. Stem Cells From Hair Follicle To Repair Nerve Damage
2. Cloning From Mice Hair Follicle Stem Cell
3. White Cells Count Can Predict Heart Attack Death Risk
4. Over-The-Counter Drugs May Prevent Alzheimers
5. Elevated Ozone Levels Hurt Sperm Count
6. WHO Declares Vietnam First Country to Control SARS
7. Probable cases of SARS- A Countrywise breakdown
8. Drug In Asthma inhaler Found To Counteract Benefits
9. Counting Calories Might Be The Ideal Way To Stay Healthy
10. The Counter Effect Of Alzheimers Drug
11. Decisions On End-of-Life Treatment Found To Vary From Country To Country
Post Your Comments:
Other Medicine News:Health News:Biologic Drugs, Particularly Centocor/Janssen-Cilag's Stelara and Abbott/Eisai's Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017 2Health News:New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals 2Health News:New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals 3Health News:Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 2Health News:The National Health Service and Attainia Move to Modernize Medical Capital Equipment Budgeting and Planning for the United Kingdom 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees 2
Breaking Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Microsoft Rogue Internet Pharmacy Problem Fixed 3F Not So Fast Say Researchers 54512 1Microsoft Rogue Internet Pharmacy Problem Fixed 3F Not So Fast Say Researchers 54512 2Orchids and fungi partners for life 9571 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 1First 5 California Approves 2481 4 Million Contribution to Help Restore Healthy Families Programs Viability 54507 2